Advertisement

Topics

Alexion snags EU yes for new Soliris indication

06:45 EDT 23 Aug 2017 | BioPharmaDive

The European Commission extended its approval of Soliris, allowing Alexion to sell the drug for another rare condition.

Original Article: Alexion snags EU yes for new Soliris indication

NEXT ARTICLE

More From BioPortfolio on "Alexion snags EU yes for new Soliris indication"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...